Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Trunzer

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Medicinal Chemistry|December 26, 2008
Metabolic soft spot identification and compound optimization in early discovery phases using MetaSite and LC-MS/MS validationMarkus Trunzer, Bernard Faller, Alfred Zimmerlin
Rapid Communications in Mass Spectrometry : RCM|February 14, 2007
Comparison of a two-dimensional liquid chromatography/mass spectrometry approach with a chip-based nanoelectrospray device for structural elucidation of metabolites in a human ADME study using a quadrupole time-of-flight mass spectrometerMarkus Trunzer, Daniel Graf, Michael Kiffe
Rapid Communications in Mass Spectrometry : RCM|February 15, 2007
Two-dimensional liquid chromatography/mass spectrometry set-up for structural elucidation of metabolites in complex biological matricesMichael Kiffe, Daniel Graf, Markus Trunzer
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 9, 2011
CYP3A time-dependent inhibition risk assessment validated with 400 reference drugsAlfred Zimmerlin, Markus Trunzer, Bernard Faller
Journal of Chromatography. A|May 1, 2007
Cytostar-T plates--a valid alternative for microplate scintillation counting of low radioactivity in combination with high-performance liquid chromatography in drug metabolism studies?Michael Kiffe, Robert Nufer, Markus Trunzer, et al.
Chemical Research in Toxicology|March 19, 2024
Deep Learning Models Compared to Experimental Variability for the Prediction of CYP3A4 Time-Dependent InhibitionAndrin Fluetsch, Markus Trunzer, Grégori Gerebtzoff, et al.
Molecular Pharmaceutics|November 28, 2022
Multispecies Machine Learning Predictions of In Vitro Intrinsic Clearance with Uncertainty Quantification AnalysesRaquel Rodríguez-Pérez, Markus Trunzer, Nadine Schneider, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 15, 2024
Improving In Vitro-In Vivo Extrapolation of Clearance Using Rat Liver Microsomes for Highly Plasma Protein-Bound MoleculesMarkus Trunzer, Joana Teigão, Felix Huth, et al.
Journal of Mass Spectrometry : JMS|February 3, 2017
Evaluation of relative MS response factors of drug metabolites for semi-quantitative assessment of chemical liabilities in drug discoveryJoachim Blanz, Gareth Williams, Jerôme Dayer, et al.
Journal of Medicinal Chemistry|October 31, 2023
Design of a Supersoft Topical JAK Inhibitor, Which Is Effective in Human Skin but Rapidly Deactivated in BloodGebhard Thoma, Odile Decoret, Eric Vangrevelinghe, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Medicinal Chemistry|December 26, 2008
Metabolic soft spot identification and compound optimization in early discovery phases using MetaSite and LC-MS/MS validationMarkus Trunzer, Bernard Faller, Alfred Zimmerlin
Rapid Communications in Mass Spectrometry : RCM|February 14, 2007
Comparison of a two-dimensional liquid chromatography/mass spectrometry approach with a chip-based nanoelectrospray device for structural elucidation of metabolites in a human ADME study using a quadrupole time-of-flight mass spectrometerMarkus Trunzer, Daniel Graf, Michael Kiffe
Rapid Communications in Mass Spectrometry : RCM|February 15, 2007
Two-dimensional liquid chromatography/mass spectrometry set-up for structural elucidation of metabolites in complex biological matricesMichael Kiffe, Daniel Graf, Markus Trunzer
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 9, 2011
CYP3A time-dependent inhibition risk assessment validated with 400 reference drugsAlfred Zimmerlin, Markus Trunzer, Bernard Faller
Journal of Chromatography. A|May 1, 2007
Cytostar-T plates--a valid alternative for microplate scintillation counting of low radioactivity in combination with high-performance liquid chromatography in drug metabolism studies?Michael Kiffe, Robert Nufer, Markus Trunzer, et al.
Chemical Research in Toxicology|March 19, 2024
Deep Learning Models Compared to Experimental Variability for the Prediction of CYP3A4 Time-Dependent InhibitionAndrin Fluetsch, Markus Trunzer, Grégori Gerebtzoff, et al.
Molecular Pharmaceutics|November 28, 2022
Multispecies Machine Learning Predictions of In Vitro Intrinsic Clearance with Uncertainty Quantification AnalysesRaquel Rodríguez-Pérez, Markus Trunzer, Nadine Schneider, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 15, 2024
Improving In Vitro-In Vivo Extrapolation of Clearance Using Rat Liver Microsomes for Highly Plasma Protein-Bound MoleculesMarkus Trunzer, Joana Teigão, Felix Huth, et al.
Journal of Mass Spectrometry : JMS|February 3, 2017
Evaluation of relative MS response factors of drug metabolites for semi-quantitative assessment of chemical liabilities in drug discoveryJoachim Blanz, Gareth Williams, Jerôme Dayer, et al.
Journal of Medicinal Chemistry|October 31, 2023
Design of a Supersoft Topical JAK Inhibitor, Which Is Effective in Human Skin but Rapidly Deactivated in BloodGebhard Thoma, Odile Decoret, Eric Vangrevelinghe, et al.
Pageof 2